| Opella Healthcare Switzerland AG - Telfast 180, überzogene Tabletten | | 54204 | | 03 | | Telfast 180 | | überzogene Tabletten | | R06AX26 | | Fexofenadine | | 26.06.1997 | | |
| | Composition | | fexofenadini hydrochloridum 180 mg, cellulosum microcristallinum, amylum pregelificatum, carmellosum natricum conexum corresp. natrium 0.18 mg, magnesii stearas, Überzug: hypromellosum, polyvidonum K 29-32, E 171, silica colloidalis anhydrica, macrogolum 400, E 172 (rubrum), E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | überzogene Tabletten | | | | | Active Agent | Dose |
|---|
| Fexofenadine Hydrochloride | 180 mg |
| | BAG: Active Agent | Dose |
|---|
| Fexofenadine Hydrochloride | 180 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Rubrum) | | | | Amylum Pregelificatum | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Polyvidonum K | 29-32 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
